Jordanna S. Sevitz

Jordanna S. Sevitz

Auto-generated profile, based on publicly available information

Jordanna S. Sevitz

Laboratory for the Study of Upper Airway Dysfunction, Department of Biobehavioral Sciences, Teachers College, Columbia University, New York, NY

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 November 2022 in Movement Disorders
Verified
Journal Article
Closed access
MTMichelle S. Troche
Michelle S. Troche
JCJames Curtis
James Curtis
JSJordanna S. Sevitz
Jordanna S. Sevitz
ADAvery E. Dakin
Avery E. Dakin
SPSarah E. Perry
Sarah E. Perry
KHKaren W. Hegland
Karen W. Hegland

7 March 2024 in American Journal of Speech-Language Pathology
Verified
Journal Article
Closed access
SPSarah E. Perry
Sarah E. Perry
MTMichelle Troche
Michelle Troche
JHJessica E. Huber
Jessica E. Huber
JCJames Curtis
James Curtis
BKBrianna Kiefer
Brianna Kiefer
DBDeanna Britton
Deanna Britton
Purpose: This systematic review represents an update to previous reviews of the literature addressing behavioral management of respiratory/phonatory dysfunction in individuals with dysarthria due to neurodegenerative disease. Method: Multiple electronic database searches and hand searches of prominent speech-language pathology journals were conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses standards. Results: The search yielded 1,525 articles, from which 88 met inclusion criteria and were reviewed by two blinded co-investigators. A large range of therapeutic approaches have been added to the evidence base since the last review, including expiratory muscle strength training, singing, and computer- and device-driven programs, as well as a variety of treatment modalities, including teletherapy. Evidence for treatment in several different population groups—including cerebellar ataxia, myotonic dystrophy, autosomal recessive spastic ataxia of Charlevoix–Saguenay, Huntington's disease, multiple system atrophy, and Lewy body dementia—were added to the current review. Synthesis of evidence quality provided strong evidence in support of only one behavioral intervention: Lee Silverman Voice Treatment Program (LSVT LOUD) in people with Parkinson's disease. No other treatment approach or population included in this review demonstrated more than limited evidence, reflecting that these approaches/populations require urgent further examination. Conclusion: Suggestions about where future research efforts could be significantly strengthened and how clinicians can apply research findings to their practice are provided. Supplemental Material: https://doi.org/10.23641/asha.24964473

7 December 2022 in Dysphagia
Verified
Journal Article
Closed access
PDF file
JSJordanna S. Sevitz
Jordanna S. Sevitz
SPSarah E. Perry
Sarah E. Perry
JBJames C. Borders
James C. Borders
ADAvery E. Dakin
Avery E. Dakin
JCJames A. Curtis
James A. Curtis
MTMichelle S. Troche
Michelle S. Troche

16 November 2022 in American Journal of Speech-Language Pathology
Verified
Journal Article
Open access
JSJordanna S. Sevitz
Jordanna S. Sevitz
JBJames C. Borders
James C. Borders
ADAvery E. Dakin
Avery E. Dakin
BKBrianna R. Kiefer
Brianna R. Kiefer
RARoy N. Alcalay
Roy N. Alcalay
MTMichelle S. Troche
Michelle S. Troche
Purpose: Airway protective deficits (swallowing and cough) greatly reduce health and quality of life and are a pervasive consequence of neurodegenerative movement disorders. Expiratory muscle strength training (EMST) and cough skill training (CST) are two treatment approaches to improve airway protection; however, many patients are unable to access these treatments. Telehealth may improve access to care, but it remains unknown whether these treatments are feasible and efficacious via telehealth. This study aimed to determine the practical feasibility and preliminary treatment effect of EMST and CST via telehealth. Method: Twenty participants with movement disorders completed 4 weeks of EMST and 2 weeks of CST, including two clinician-directed treatment sessions via telehealth and 3 days of home practice per week. Feasibility was calculated for each treatment. Practical feasibility was defined as completing treatment (EMST or CST) and obtaining the relevant outcome measures—a proxy of maximum expiratory pressure (pMEP) for EMST and peak expiratory flow rate (PEFR) for CST—within a 30-min session/period. Session factors that may have influenced feasibility were examined. Preliminary treatment effect was defined as changes in pMEP and PEFR. Results: Time taken to obtain pMEP and complete EMST was 17.48 min, and time taken to obtain PEFR and complete CST was 17.69 min. pMEP, single voluntary cough PEFR, and sequential voluntary cough PEFR increased from pre- to posttreatment. Conclusions: Findings suggest that the delivery of EMST and CST is feasible via telehealth and yield improvements to pMEP and PEFR. This has important implications for expanding service delivery of airway protective interventions and reducing health care disparities in people with neurodegenerative movement disorders. Supplemental Material: https://doi.org/10.23641/asha.21357669


30 November 2023 in The Cerebellum
Verified
Journal Article
Closed access
PDF file
ELEmilie R. Lowell
Emilie R. Lowell
JBJames C. Borders
James C. Borders
SPSarah E. Perry
Sarah E. Perry
ADAvery E. Dakin
Avery E. Dakin
JSJordanna S. Sevitz
Jordanna S. Sevitz
MTMichelle S. Troche
Michelle S. Troche